Fund Holdings — EcoR1 Capital, LLC

Total Portfolio Value:
$1.68B
Total Bought:
$282.19M
Total Sold:
$394.84M
Net Transaction:
-$112.65M
Notable People:
Scott Eric Perlen
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Apellis Pharmaceuticals Inc
COM
11,890,84311,895,808+4,965$379.44M$260.16M15.45%-$119.28M
Jazz Pharmaceuticals plcSHS USD(JAZZ)1,706,4691,706,4690$210.15M$211.86M12.58%+$1.71M
Zymeworks Inc.(ZYME)15,028,07917,259,548+2,231,469$220.01M$205.56M12.21%-$14.45M
Anaptysbio Inc7,873,4487,880,094+6,646$104.24M$146.49M8.70%+$42.25M
Crinetics Pharmaceuticals In4,288,1204,288,1200$219.25M$143.82M8.54%-$75.43M
Prothena Corp PlcSHS
SHS
11,584,28011,584,2800$160.44M$143.36M8.51%-$17.09M
Sarepta Therapeutics, Inc.(SRPT)770,0001,292,386+522,386$93.62M$82.48M4.90%-$11.14M
Xencor, Inc.(XNCR)6,144,7676,144,7670$141.21M$65.38M3.88%-$75.83M
CRISPR Therapeutics AGNAMEN AKT(CRSP)1,389,2761,389,2760$54.68M$47.28M2.81%-$7.40M
uniQure N.V.SHS(QURE)3,400,0003,988,971+588,971$60.04M$42.28M2.51%-$17.76M
Janux Therapeutics, Inc.(JANX)1,469,8181,469,8180$78.69M$39.69M2.36%-$39.01M
Immunome, Inc.(IMNM)3,879,4154,079,415+200,000$41.20M$27.45M1.63%-$13.74M
Eton Pharmaceuticals, Inc.(ETON)1,829,6031,939,288+109,685$24.37M$25.17M1.49%+$801.6K
Madrigal Pharmaceuticals, Inc.(MDGL)75,00075,0000$23.14M$24.84M1.48%+$1.70M
ORIC Pharmaceuticals, Inc.(ORIC)3,418,0683,418,0680$27.58M$19.07M1.13%-$8.51M
Akero Therapeutics Inc0440,000+440,000$0$17.81M1.06%+$17.81M
Kura Oncology, Inc.(KURA)3,557,2692,640,298-916,971$30.98M$17.43M1.03%-$13.56M
Tectonic Therapeutic, Inc.(TECX)849,143935,121+85,978$39.20M$16.56M0.98%-$22.64M
Avidity Biosciences Inc557,576557,5760$16.21M$16.46M0.98%+$245.3K
Neurogene Inc.(NGNE)1,271,3421,271,3420$29.06M$14.89M0.88%-$14.18M
Tango Therapeutics, Inc.(TNGX)10,630,73610,630,7360$32.85M$14.56M0.86%-$18.28M
Voyager Therapeutics, Inc.(VYGR)3,917,5463,917,5460$22.21M$13.24M0.79%-$8.97M
Beam Therapeutics Inc.(BEAM)0526,685+526,685$0$10.29M0.61%+$10.29M
MBX Biosciences, Inc.(MBX)1,259,2731,259,2730$23.21M$9.29M0.55%-$13.91M
Ginkgo Bioworks Holdings, Inc.CL A(DNA)1,743,3441,462,328-281,016$17.12M$8.34M0.49%-$8.78M
Replimune Group, Inc.(REPL)850,341850,3410$10.30M$8.29M0.49%-$2.01M
Bicycle Therapeutics PlcADS910,000910,0000$12.74M$7.73M0.46%-$5.01M
Day One Biopharmaceuticals I
COM
862,068862,0680$10.92M$6.84M0.41%-$4.09M
Verve Therapeutics Inc1,250,0001,250,0000$7.05M$5.71M0.34%-$1.34M
Adaptimmune Therapeutics plcADR(ADAPY)27,404,07027,404,0700$14.76M$5.40M0.32%-$9.36M
Lakefront Biotherapeutics NVADR(LKFT)155,006155,0060$4.26M$3.89M0.23%-$368.9K
Whitehawk Therapeutics, Inc.(WHWK)345,2532,082,000+1,736,747$1.09M$3.71M0.22%+$2.62M
Atara Biotherapeutics Inc532,134573,183+41,049$7.08M$3.40M0.20%-$3.68M
Solid Biosciences Inc0744,450+744,450$0$2.75M0.16%+$2.75M
Keros Therapeutics, Inc.(KROS)187,500187,5000$2.97M$1.91M0.11%-$1.06M
Nuvation Bio Inc.W EXP 02 10 202(NUVB)963,333963,3330$2.56M$1.70M0.10%-$867.0K
Relay Therapeutics, Inc.(RLAY)641,426641,4260$2.64M$1.68M0.10%-$962.1K
Kalaris Therapeutics, Inc.(KLRS)0201,718+201,718$0$1.62M0.10%+$1.62M
Prime Medicine, Inc.(PRME)700,000700,0000$2.04M$1.39M0.08%-$651.0K
Metsera Inc050,000+50,000$0$1.36M0.08%+$1.36M
TScan Therapeutics, Inc.(TCRX)5,000,000662,833-4,337,167$15.20M$914.7K0.05%-$14.29M
Surrozen, Inc.W EXP 08 01 203(SRZN)66,66566,6650$956.6K$777.3K0.05%-$179.3K
Aligos Therapeutics, Inc.(ALGS)255,57388,569-167,004$10.18M$730.7K0.04%-$9.45M
Upstream Bio, Inc.(UPB)60,00060,0000$986.4K$367.2K0.02%-$619.2K
Allovir Inc408,6880-408,688$3.95M$0—-$3.95M
Artiva Biotherapeutics, Inc.(ARTV)41,4530-41,453$417.8K$0—-$417.8K
Arvinas, Inc.(ARVN)6,726,4910-6,726,491$128.95M$0—-$128.95M
Atea Pharmaceuticals, Inc.(AVIR)3,341,6530-3,341,653$11.19M$0—-$11.19M
Cargo Therapeutics Inc1,470,0000-1,470,000$21.20M$0—-$21.20M
Design Therapeutics, Inc.(DSGN)426,6830-426,683$2.63M$0—-$2.63M
Dyne Therapeutics, Inc.(DYN)555,6440-555,644$13.09M$0—-$13.09M
Fate Therapeutics, Inc.(FATE)3,049,4050-3,049,405$5.03M$0—-$5.03M
Generation Bio Co2,046,8670-2,046,867$2.17M$0—-$2.17M
Hookipa Pharma Inc388,8610-388,861$781.6K$0—-$781.6K
Kymera Therapeutics, Inc.(KYMR)350,0000-350,000$14.08M$0—-$14.08M
Mersana Therapeutics Inc11,328,0000-11,328,000$16.20M$0—-$16.20M
MoonLake ImmunotherapeuticsCL A(MLTX)332,5220-332,522$18.01M$0—-$18.01M
Neumora Therapeutics, Inc.(NMRA)2,071,4500-2,071,450$21.96M$0—-$21.96M
Springworks Therapeutics Inc1,560,0000-1,560,000$56.36M$0—-$56.36M
Third Harmonic Bio Inc3,182,4440-3,182,444$32.75M$0—-$32.75M
Page 1 of 1
EcoR1 Capital, LLC — 13F Holdings — Q1 2025 | TickerTrail